The owner of a Washington state research clinic is accused of swindling pharmaceutical companies out of at least $274,000 by falsifying medical records to collect payments for participating in a trial of an experimental treatment for patients who take daily opioids.
The U.S. district attorney for eastern Washington on Thursday unsealed a grand jury indictment against Sami Anwar, owner of Mid Columbia Research and Zain Research in Richland, Washington.
The companies were hired by Braeburn Pharmaceuticals to participate in a clinical trial of an investigation drug known as CAM 2038, intended t...
Comments